Survival Benefit of Living-Donor Liver Transplant.

ABSTRACT:

Importance

Despite the acceptance of living-donor liver transplant (LDLT) as a lifesaving procedure for end-stage liver disease, it remains underused in the United States. Quantification of lifetime survival benefit and the Model for End-stage Liver Disease incorporating sodium levels (MELD-Na) score range at which benefit outweighs risk in LDLT is necessary to demonstrate its safety and effectiveness.

Objective

To assess the survival benefit, life-years saved, and the MELD-Na score at which that survival benefit was obtained for individuals who received an LDLT compared with that for individuals who remained on the wait list.

Design, setting, and participants

This case-control study was a retrospective, secondary analysis of the Scientific Registry of Transplant Reci

SUBMITTER: Jackson WE 

PROVIDER: S-EPMC9350845 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature